Energesis Pharmaceuticals, Inc.
PrivateLast Round
Grant
Sep 1, 2021
Total Funding Raised
$5.55M
Company Overview
Energesis Pharmaceuticals, Inc. is a biotechnology company that develops therapeutic drugs for the treatment of obesity, diabetes, and related metabolic diseases by leveraging brown adipose tissue biology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Energesis Pharmaceuticals, Inc. Comparables
Compare Energesis Pharmaceuticals, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Adipo Therapeutics | 86% | |
| Eolo Pharma | 86% | |
| Brite Therapeutics | 85% | |
Energesis Pharmaceuticals, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 1, 2021 | ||||
| Grant | Sep 30, 2019 | ||||
| Grant | May 27, 2015 | ||||
| Accelerator | Oct 1, 2010 |
Energesis Pharmaceuticals, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Massachusetts Life Sciences Center | Grant |
| National Institute of Diabetes and Digestive and Kidney Diseases | Grant |
| MassChallenge Israel | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 2, 2025
Grew 100% QoQ from 3 to 6 employees.
- Sep 1, 2021
$1M grant from National Institute of Diabetes and Digestive and Kidney Diseases.
Energesis Pharmaceuticals, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Energesis Pharmaceuticals, Inc.'s valuation, stock price, and market status.